Q0249 Tocilizumab for covid-19
Q-Codes
Also known as: Actemra COVID, tocilizumab for COVID, IL-6 antagonist
Tocilizumab for Coronavirus Disease 2019 (COVID-19) infection, an interleukin-6 receptor antagonist used to reduce severe inflammation in hospitalized COVID-19 patients.
Clinical Context
Used for hospitalized patients with COVID-19 pneumonia requiring supplemental oxygen or mechanical ventilation. Reduces mortality and need for mechanical ventilation in moderate to severe disease.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.